123 related articles for article (PubMed ID: 26317917)
1. Impact of a Contralateral Tumor Nodule on Survival in Non-Small-Cell Lung Cancer.
Morris ZS; Cannon DM; Morris BA; Bentzen SM; Kozak KR
J Thorac Oncol; 2015 Nov; 10(11):1608-15. PubMed ID: 26317917
[TBL] [Abstract][Full Text] [Related]
2. Tumor, node and metastasis classification of lung cancer--M1a versus M1b--analysis of M descriptors and other prognostic factors.
Sánchez de Cos Escuín J; Abal Arca J; Melchor Íñiguez R; Miravet Sorribes L; Núñez Ares A; Hernández Hernández JR; García Arangüena L; Núñez Delgado M; Pavón Fernández MJ; Francisco Corral G; de Esteban Júlvez L; González Budiño MT; Abad Cavaco F; Ansótegui Barrera E; Andreo García F; Serra Mitjans M; Hernández Rodríguez H
Lung Cancer; 2014 May; 84(2):182-9. PubMed ID: 24629637
[TBL] [Abstract][Full Text] [Related]
3. Does Lymph Node Metastasis Have a Negative Prognostic Impact in Patients with NSCLC and M1a Disease?
Dai C; Ren Y; Xie D; Zheng H; She Y; Fei K; Jiang G; Chen C
J Thorac Oncol; 2016 Oct; 11(10):1745-54. PubMed ID: 27567989
[TBL] [Abstract][Full Text] [Related]
4. The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy.
Fernandes AT; Mitra N; Xanthopoulos E; Evans T; Stevenson J; Langer C; Kucharczuk JC; Lin L; Rengan R
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):340-7. PubMed ID: 22104359
[TBL] [Abstract][Full Text] [Related]
5. Surgical Intervention Improves Survival for Metastatic Non-Small Cell Lung Cancer Patients.
Shen H; Cao Y; Li X; Tan Y; Chen J; Yang Z; Kong Y; Yuan Y
Medicine (Baltimore); 2016 May; 95(21):e3800. PubMed ID: 27227958
[TBL] [Abstract][Full Text] [Related]
6. M1b Disease in the 8th Edition of TNM Staging of Lung Cancer: Pattern of Single Extrathoracic Metastasis and Clinical Outcome.
Park H; Dahlberg SE; Lydon CA; Araki T; Hatabu H; Rabin MS; Johnson BE; Nishino M
Oncologist; 2019 Aug; 24(8):e749-e754. PubMed ID: 30696724
[TBL] [Abstract][Full Text] [Related]
7. The prognosis after contraindicated surgery of NSCLC patients with malignant pleural effusion (M1a) may be better than expected.
Ren Y; Dai C; Shen J; Liu Y; Xie D; Zheng H; He J; Liang W; Jiang G; Fei K; Yang P; He J; Chen C
Oncotarget; 2016 May; 7(18):26856-65. PubMed ID: 27057627
[TBL] [Abstract][Full Text] [Related]
8. Survival of M1a Non-Small Cell Lung Cancer Treated Surgically: A Retrospective Single-Center Study.
Liu T; Liu H; Wang G; Zhang C; Liu B
Thorac Cardiovasc Surg; 2015 Oct; 63(7):577-82. PubMed ID: 25893920
[TBL] [Abstract][Full Text] [Related]
9. Capecitabine and cisplatin chemotherapy (XP) alone or sequentially combined chemoradiotherapy containing XP regimen in patients with three different settings of stage IV esophageal cancer.
Lee SS; Kim SB; Park SI; Kim YH; Ryu JS; Song HY; Shin JH; Jung HY; Lee GH; Choi KD; Cho KJ; Kim JH
Jpn J Clin Oncol; 2007 Nov; 37(11):829-35. PubMed ID: 17951334
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Survival of American Joint Committee on Cancer 8th Edition Staging Descriptors for Clinical M1a Non-Small Cell Lung Cancer.
Kumar A; Xu B; Srinivasan D; Potter AL; Raman V; Lanuti M; Yang CJ; Auchincloss HG
Chest; 2024 Mar; 165(3):725-737. PubMed ID: 37544427
[TBL] [Abstract][Full Text] [Related]
11. The prognostic impact of lymph node metastasis in patients with non-small cell lung cancer and distant organ metastasis.
Yang J; Peng A; Wang B; Gusdon AM; Sun X; Jiang G; Zhang P
Clin Exp Metastasis; 2019 Oct; 36(5):457-466. PubMed ID: 31420766
[TBL] [Abstract][Full Text] [Related]
12. Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors.
Griffioen GH; Toguri D; Dahele M; Warner A; de Haan PF; Rodrigues GB; Slotman BJ; Yaremko BP; Senan S; Palma DA
Lung Cancer; 2013 Oct; 82(1):95-102. PubMed ID: 23973202
[TBL] [Abstract][Full Text] [Related]
13. [Curative surgical treatment options for patients with non-small cell lung cancer (NSCLC) and solitary pulmonary metastasis].
Tönnies M; Kollmeier J; Bauer TT; Griff S; Kaiser D
Pneumologie; 2012 Apr; 66(4):218-23. PubMed ID: 22477482
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003.
Morgensztern D; Waqar S; Subramanian J; Gao F; Trinkaus K; Govindan R
J Thorac Oncol; 2012 Oct; 7(10):1479-84. PubMed ID: 22982648
[TBL] [Abstract][Full Text] [Related]
15. Surgery for M1A Non-Small-Cell Lung Cancer With Additional Pulmonary Nodules in a Contralateral Lobe.
Kumar A; Kumar S; Gilja S; Mathey-Andrews CA; Potter AL; Jeffrey Yang CF; Auchincloss HG
J Surg Res; 2024 Mar; 295():102-111. PubMed ID: 38006777
[TBL] [Abstract][Full Text] [Related]
16. Survival improvements for advanced stage nonbronchioloalveolar carcinoma-type nonsmall cell lung cancer cases with ipsilateral intrapulmonary nodules.
Zell JA; Ou SH; Ziogas A; Anton-Culver H
Cancer; 2008 Jan; 112(1):136-43. PubMed ID: 17960795
[TBL] [Abstract][Full Text] [Related]
17. Relationship between tumor size and survival in non-small-cell lung cancer (NSCLC): an analysis of the surveillance, epidemiology, and end results (SEER) registry.
Zhang J; Gold KA; Lin HY; Swisher SG; Xing Y; Lee JJ; Kim ES; William WN
J Thorac Oncol; 2015 Apr; 10(4):682-90. PubMed ID: 25590605
[TBL] [Abstract][Full Text] [Related]
18. Definitive radiotherapy for stage I nonsmall cell lung cancer: a population-based study of survival.
Milano MT; Zhang H; Usuki KY; Singh DP; Chen Y
Cancer; 2012 Nov; 118(22):5572-9. PubMed ID: 22544655
[TBL] [Abstract][Full Text] [Related]
19. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
